Meet the Worldwide Team

Worldwide Clinical Trials started out more than 30 years ago as a small science team with a big goal: To always provide authentic, personalized attention to our partners. And as the industry has grown, CROs have merged, and trials have grown increasingly complex, we haven’t forgotten what truly matters: People.

With more than 3,000 employees in more than 60 countries around the world, we’re still staying true to those roots. Our team is dedicated to staying accessible, flexible, and solution-focused to ensure our partners not only have the best possible outcomes – but they also know their Worldwide team is only a call away.

Explore more about our team below.

  • Leadership
  • Sales
  • Therapeutic Experts
    • Cardiovascular
    • General Medicine
    • Neuroscience
    • Oncology
    • Rare Disease
    • Endocrine & Metabolic
    • Cell & Gene Therapy
  • Solutions
    • Pre IND & Phase I
    • Phase II-III
    • Phase IV & Real World Evidence
    • Biosimilars
    • Regulatory

Olutola O Adetona, MD, MPH, CPI

Medical Director/Certified Principal Investigator – Early Phase Clinical Operations

Sherilyn Adcock, RPh, PhD

Chief Scientific Officer, Early Phase Development

Jeff Almrud, PhD

Senior Director, Project Management

Derek Ansel, MS, LCGC

Executive Director, Therapeutic Strategy Lead, Rare Diseases

Tamara Ast, PhD

Executive Vice President, Global Therapeutic Lead, Neuroscience

Rolana Avrumson, MS

Vice President of Clinical Projects, Clinical Assessment Technologies

Tom Babic, MD, PhD

Vice President, Scientific Solutions, Neuroscience

Scott Beasley

Executive Director, Project Management, MASH, Cardiovascular & Metabolic

Lucy Bennett

Executive Director, Project Management

Richard Bennett

Senior Director, Therapeutic Strategy Lead, Neuroscience

Peter Benton, MBA

President and Chief Executive Officer

Peter Böhm

Senior Director Project Management, Neuroscience – Spain

David Bowser, MBA

Executive Vice President and Chief Operating Officer

Jake Boyd

Senior Director, Project Management

Emmet Browne

Vice President, Commercial EU

Mireille Cantarini, BSc, MB, ChB, MRCP, FFPM

Senior Medical Director, Medical Affairs, Oncology

Angelico Carta, MD


Idil Cavus, MD, PhD

Vice President, Central Nervous System Therapeutic Area Lead, Medical Affairs

Nathan Chadwick

Senior Director, Therapeutic Strategy Lead, Rare Disease

Cheryl Chapman

Executive Director, Project Management, Oncology

Steve Chriscoe

Vice President, Project Management, Oncology

Joy Clark

Chief People Officer

Stefan Comhaire

Executive Director, Project Management

Matt Cooper, PhD

Executive Director, Therapeutic Strategy Lead, Oncology

MarieElena Cordisco

Senior Director Therapeutic Strategy Lead Metabolic

Rosemarie Corrigan, FRQA, FRSB

Executive Vice President, Global Quality

Martin Cummins

Executive Director, Project Management

Sara Davis

Executive Vice President and Chief Commercial Officer

Craig Dorer-Abadia

Senior Director, Project Management, Oncology

Natalia Drosopoulou, PhD

Vice President, Project Management, Neuroscience

Pete Duprat

Senior Vice President, Commercial, Early Phase

Dana F. Durst

Executive Director, Site Activation & Regulatory Therapeutic Lead, Oncology

Barry Dussault

Executive Director, Project Management, Franchise Area Lead, Pain

Jim Eamma

Executive Director, Therapeutic Strategy Lead, Oncology & Hematology

Leimin (Perry) Fan, PhD

Associate Director, Method Development

Ted Finlan

Senior Vice President, Project Planning & Administration

Gary Fishbein, MD, MPH

Vice President, Therapeutic Area Lead, Oncology

Julia Forte

Senior Director, Project Management

Andre Ganem

Senior Vice President, Global Site Management

Virgilio Garcia Lerma

Senior Director, Regulatory Pre-Award Strategy

Jason Hamilton, PhD

Associate Director, Method Validation

Monika Iten, PhD

Vice President Project Management, Cardiovascular

Bartosz Janikowski, MD

Senior Vice President, Medical Sciences


VP, Regulatory Science, Strategy and Innovation

Lisle R. Kingery, PhD

Therapeutic Strategy Lead, Neuroscience

Ariela Knallevsky, MD

Executive Medical Director, Medical Affairs

Richard Koenig

Executive Director, Project Management, Psychiatry and Neuroscience Rare Diseases

Jayaprakash (JP) Kotha, MBBS, PhD, ASCP (SH)

Vice President, Bioanalytical Laboratory

Peter Lammers

Executive Vice President of Marketing and Commercial Operations

Barry Lederman

Chief Financial Officer

Lisa Leuzzi

Vice President, Project Management, Psychiatry and Neurology

Drew Matheson

Executive Director. Franchise Area Lead Respiratory Medicine and Infectious Disease

Mike Mencer

Executive Vice President and General Manager, Early Phase

Juliane K. Mills, MS, MPH

Senior Director, Therapeutic Strategy Lead, Rare Disease

Christine Moore, PhD

Vice President, Neuroscience, Scientific Solutions

Giovanna Morley

Vice President, BD Americas

Anne-Claude Muratet

Executive Director, Project Management, Neurology and Rare Diseases

Michael Murphy, MD, PhD

Chief Medical and Scientific Officer

Gerardo Pascuali

Executive Director, Regional Clinical Operations, Latin America

Paula Penney

Executive Director, Project Management, Alzheimer’s Disease and other Dementias

Daniel A. Perez, CCRP

Director, Health Equity Strategy

Vladimir Radovic, MD

Senior Medical Director, Medical Affairs

Amy Raymond, PhD, PMP

Executive Director, Therapeutic Strategy Lead, Rare Disease & Cellular and Genetic Medicines

Joanna Reeder

Vice President, Project Management, Other and Rare Diseases

Henry J. Riordan, PhD

Chief Development Officer

Seth Schulman, MD

Senior Medical Director

Lona Sheeran

Senior Vice President, Clinical Operations Early Phase

Marie T. Simerly, PMP

Senior Director, Project Management Early Phase

Jeffrey G. Stark, PhD

Senior Director, Head of Pharmacokinetics

Nicola Thorne

Vice President of Oncology Project Management

Attila Timar-Peregrin, MD, PhD

Executive Director, Medical Affairs & Therapeutic Area Lead, Digestive Diseases

Eteri Tsetskhladze, MD, PhD, FESC, FACC

Vice President, General Medicine Medical Lead, Medical Affairs

Mary Glenn Vreeland

Senior Director, Real-World Evidence

Clare Wallis

President of Oncology Business Unit

Tom Zhang, PhD

Chief Scientific Officer, Large Molecule Bioanalysis

Rafal Ziecina, MD, PhD

Executive Director, Scientific Solutions, Cardiovascular, Endocrine & Metabolic

See what Worldwide Clinical Trials can do for you.

Fill out the brief form to get in touch.